ヒトにおけるヘパリン抗凝固の逆転のためのプロタミンに対する再結合血小板因子4のランダム化試験

G J Dehmer1, R A Lange, D A Tate

  • 1Cardiac Catheterization Laboratories, University of North Carolina Hospitals, Chapel Hill 27514, USA.

Circulation
|November 1, 1996
PubMed
まとめ

再結合血小板因子4 (rPF4) は,ヘパリンの抗凝固作用を有意な副作用なしに効果的に逆転させ,心臓の手術におけるプロタミンより安全な代替品として有望を示しました.

関連する概念動画

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...